Amos Victor Oluwaloseyi, Odeyemi Aduragbemi Noah, Ajayi Lydia Oluwatoyin, Yusuff Gaffar, Olotu Moses, Akano Oyedayo Phillips, Moyinoluwa Comfort Onaolapo, Bolade Sylvester Olateju, Adelakun Ademola Ayodele, Oyowvi Mega Obukohwo, Ajayi Ayodeji Folorunsho
Journal: Clinica chimica acta; international journal of clinical chemistry 2024;556():117850
PMID: 38431200
This review explores the use of metabolomics in male infertility. Metabolomics, an evolving omics technology that targets the products of cellular metabolism, is valuable for elucidating underlying pathophysiology of many disorders including male infertility. The identification of reliable biomarkers is essential for accurate diagnosis and for developing precision therapeutics for those afflicted by reproductive dysfunction. Unfortunately, despite significant progress to date, the intricate relationships between these metabolic pathways and male infertility remain elusive. It is clear, however, that additional research is required to more fully characterize the role of metabolomics in this disorder and in the potential development of targeted therapies for precision medicine.
Copyright © 2024. Published by Elsevier B.V.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.